Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Nomegestrol + Estradiol, Atc G03aa14 For The Period 01.08.25 - 31.07.27 (plus Extension Option 1x12 Months) Vgv Tender Dak-gesundheit 2025-12-13
Germany Open House Medicinal Department Departments Epinephrin, Atc C01ca24 2025-12-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V To The Active Ingredient Iron (iii) Derisomaltosis, Atc B03ac08 For The Time 01.08.2025 31.07.2027 2025-12-14
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Medicines With The Active Ingredient Fluorouracil (atccode 2025-12-14
Germany Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Beclometason, Atc R03al09 2025-12-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Fluorouracil, Atc D11af05 For The Time 01.08.2025 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-14
Germany Open House Medicinal Department Of Pegintereron Beta1a, Atc L03ab13 2025-12-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V To The Active Ingredient Nilotinib (except As A Dispatch In Apple Sauce) F. D. Z. 01.8.25 31.7.27 (plus Extension Option 1x12 Month) 2025-12-14
Finland Anesthesia And Intensive Care Supplies Dps 2025-12-14
France Supply Of Pharmaceutical Specialties In The Context Of Competition And New Needs For The Benefit Of Members Of The Gcs Graps Grand Est - Dynamic Acquisition System 2025-12-14
Whats app